A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

San Francisco VA Medical Center, San Francisco, CA, San Francisco, California

Kansas City VA Medical Center, Kansas City, MO, Kansas City, Missouri

Durham VA Medical Center, Durham, NC, Durham, North Carolina

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington